Translate
About
Innocan Pharma Corporation (CN:INNO) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 6 2026
Innocan Pharma Announces Closing of Additional Debenture
Mar 31 2026
Innocan Pharma Announces Offering of an Additional Debenture to Tamar Innovest
Mar 31 2026
Innocan Pharma Reports 2025 Financial Results, with Revenues at US $26.6M
Mar 16 2026
Innocan Pharma Announces Closing of a Debenture to its Largest Shareholder, Tamar Innovest
Mar 11 2026
Innocan Pharma Announces Offering of a Debenture to its Largest Shareholder, Tamar Innovest
Recent Videos
InnoCan Pharma focuses on medical CBD research and innovative drug delivery technologies for pain.
Mar 05, 2026
InnoCan Pharma Aktie - "Kanada-Buden" Pennystock #Aktien
Sep 26, 2025
Innocan Pharma Partners With an Animal Sanctuary to Bring Remedy and Hope with its LPT-CBD injection
Sep 19, 2025
Innocan’s Liposomal CBD Injection Shows Breakthrough Pain Relief in Elderly Donkey w. Osteoarthritis
Feb 11, 2025
Financials
Revenue
CA$26.61 M
Market Cap
CA$29.96 M
EPS
-0.35